Home » Topics » Regulatory » EMA

EMA
RSS

Roche files to extend indication of tocilizumab for systemic juvenile idiopathic arthritis

Oct. 21, 2010

EC grants orphan drug status for eflornithine in familial adenomatous polyposis

Oct. 21, 2010

EC grants orphan drug status for S*BIO's SB-1518 in myelofibrosis

Oct. 20, 2010

EMA recommends approval of CTI's pediatric investigation plan for Pixuvri

Oct. 20, 2010

European orphan drug status for recombinant porcine factor VIII in hemophilia A

Oct. 20, 2010

EMA grants orphan drug status for forodesine in chronic lymphocytic leukemia

Oct. 19, 2010

EC grants orphan drug status for pralatrexate in Hodgkin's lymphoma

Oct. 19, 2010

European orphan drug status for NeuroSTAT in traumatic brain injury

Oct. 18, 2010

EMA approves Twynsta single pill combination for high blood pressure

Oct. 14, 2010

Tesetaxel receives EMA orphan drug status for gastric cancer

Oct. 14, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...